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Abstract 51 
The Apolipoprotein E (ApoE) ε4 allele is the best established genetic risk factor for 52 
Alzheimer’s disease (AD) and has been previously associated with alterations in 53 
structural gray matter and changes in functional brain activity in healthy middle-aged 54 
individuals and older non-demented subjects. In order to determine the neural 55 
mechanism by which ApoE polymorphisms affect white matter (WM) structure, we 56 
investigated the diffusion characteristics of white matter tracts in carriers and non-57 
carriers of the ApoE ε4 and ε2 alleles using an unbiased whole brain analysis 58 
technique (Tract Based Spatial Statistics (TBSS)) in a healthy young adolescent 59 
(14years) cohort. A large sample of healthy young adolescents (n=575) were 60 
selected from the European neuroimaging-genetics IMAGEN study with available 61 
ApoE status and accompanying diffusion imaging data.  MR Diffusion data was 62 
acquired on 3T systems using 32 diffusion-weighted (DW) directions and 4 non-DW 63 
volumes (b-value = 1300 s/mm2 and isotropic resolution of 2.4x2.4x2.4 mm). No 64 
significant differences in WM structure were found in diffusion indices between 65 
carriers and non-carriers of the ApoE ε4 and ε2 alleles, and dose-dependent effects 66 
of these variants were not established, suggesting that differences in WM structure 67 
are not modulated by the ApoE polymorphism. In conclusion, our results suggest 68 
that microstructural properties of WM structure are not associated with the ApoE ε4 69 
and ε2 alleles in young adolescence, suggesting that the neural effects of these 70 
variants are not evident in 14-year olds and may only develop later in life.  71 
Keywords 72 
Apolipoprotein E, Diffusion Tensor Imaging, DTI, TBSS, magnetic resonance 73 
imaging, young healthy adolescents. 74 
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Introduction 75 
The Apolipoprotein E (ApoE) gene is a low density glycoprotein which has a key 76 
metabolic role in facilitating the transport and delivery of lipids such as cholesterol 77 
from one cell type to another [1,2]. A key understanding in its function beyond normal 78 
lipoprotein metabolism has led to the emergence of its role in modulating neuronal 79 
repair, brain plasticity and axonal myelination. In particular, an isoform of ApoE, 80 
ApoE ε4, has been associated with an increased risk of developing sporadic 81 
Alzheimer’s disease (AD) [3–5], whereas the ApoE ε2 isoform has been suggested 82 
to confer a protective effect against the disease [6].  83 
Neuroimaging studies of different ApoE gene polymorphisms, particularly the ApoE 84 
ε4 allele, have provided evidence of its association with changes in gray matter 85 
structure in AD patients, subjects with Mild Cognitive Impairment (MCI), and non-86 
demented elderly controls [7–10].  A majority of these findings have shown that 87 
ApoE ε4 carriers reflect greater rates of atrophy in the hippocampus and entorhinal 88 
cortex - key regions known to be affected in early AD. Further, similar neuroanatomic 89 
effects of the ApoE ε4 allele have been observed in young healthy adults (20-35 90 
years), suggesting that possession of the ε4 allele may also be associated with a 91 
neural endophenotype that is more susceptible to age-related neurodegeneration in 92 
later life [11–13]. The emergence of these findings has led to an increased interest in 93 
exploring even earlier brain differences associated with the ε4 allele. As a result, 94 
some have postulated that the neuroanatomic effect of the allele on brain 95 
phenotypes associated with AD risk could even precede birth [14].   96 
Functional MRI studies performed in healthy adults both at rest and during a 97 
memory-encoding paradigm also reveal altered patterns of brain activation in healthy 98 
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ApoE ε4 carrier subjects [15,16]. However, findings on the functional effects of the 99 
ApoE ε4 allele are mixed, and evidence for both increased and decreased brain 100 
activation have been previously reported [17].  101 
Diffusion tensor imaging (DTI) tractography is a technique that is being increasingly 102 
used to assess white matter changes in the brain by quantifying the microstructural 103 
density and orientation of axonal bundles connecting different regions of the brain 104 
[18,19]. Understanding the neural mechanism by which the ApoE polymorphism 105 
influences WM structure is crucial, particularly because ApoE plays a major role in 106 
distributing essential lipids that contribute to the development of myelin sheath 107 
[20,21].  108 
Previous DTI studies of older healthy ApoE ε4 carriers, have found reduced 109 
fractional anisotropy (FA) in the splenium of the corpus collosum [22], the cingulum 110 
bundle [23,24], and parahippocampal gyrus [25]. A recent study into younger ApoE 111 
ε4 carriers reported non-significant differences in WM structure, but found subtle 112 
differences within the prefrontal cortex between carriers and non-carriers [26]. 113 
Carriers of the ApoE ε2 allele are believed to have a decreased risk of developing 114 
AD [6], though the basis for this decreased vulnerability to the disease remains 115 
equivocal.  116 
Myelination of intra-cortical fibers progresses gradually from birth to adulthood [27], 117 
and it is likely that asynchronous brain maturation processes during adolescence, 118 
particularly synaptic pruning and changes in axon calibre, may lead to a WM network 119 
that is more susceptible to structural damage in later life [28]. Using a large sample 120 
of young healthy adolescents from the European IMAGEN study, we assessed the 121 
5 
 
diffusion characteristics of ApoE ε4, ε3 and ε2 carriers to determine if WM 122 
microstructure properties are modulated by the ApoE polymorphism.   123 
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Materials and Method 124 
Participants 125 
Data analysed for this study were obtained from healthy 14-year olds from the 126 
IMAGEN project, a European multi-centre neuroimaging-genetics study in 127 
adolescence. A total of 575 healthy adolescents were selected from the study with 128 
available diffusion imaging and ApoE genotype data. Written informed consent was 129 
obtained from all participants and their legal guardians, further information on 130 
recruitment procedures has been previously provided [29]. Participants completed an 131 
extensive battery of neuropsychological, clinical, personality and drug use 132 
assessments.  133 
For each subject, blood samples were collected for DNA analysis and extraction. 134 
Samples were subsequently genotyped using the Illumina Quad 610 and 660 arrays 135 
(Illumina, San Diego, CA, USA). Two ApoE single nucleotide polymorphisms, 136 
rs429358 (T, C) and rs7412 (C, T) were used to identify 3 allelic variants of ApoE 137 
(ε2, ε3, and ε4) in order to define a subject’s genotype. Eight subjects with an ApoE 138 
ε4 and ε2 genotype were excluded from the main analysis as previous studies have 139 
proposed an opposing neuroanatomic effect of the ApoE ε4 and ε2 alleles. The 140 
demographic characteristics of our sample are described in Table 1.  141 
Image Acquisition 142 
575 subjects (mean age 14.43 ± 0.47 years) from 5 imaging centers with compatible 143 
DTI acquisition protocols and with ApoE genotype information available were 144 
selected. A standardised imaging protocol was used to ensure homogeneity in data 145 
acquisition across different scanners [29] . MR Diffusion data was acquired on 3T 146 
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systems with the following parameters: TE=104ms, TR=15000ms, matrix size 147 
128x128, number of slices=60 and isotropic resolution of 2.4x2.4x2.4mm. Diffusion 148 
data was acquired with a b-value of 1300 s/mm2 along 32 non-collinear diffusion 149 
gradient directions and 4 non-diffusion weighted volumes. More details are available 150 
in  Schumann et al 2010 [29].  151 
Image Analysis 152 
Diffusion data was processed using ExploreDTI [30]. Data was first preprocessed to 153 
correct for eddy current distortions and head motion. For each subject the b-matrix 154 
was reoriented to provide a more accurate estimate of tensor orientations. Diffusion 155 
tensor was estimated using RESTORE [31] an automatic and iterative approach for 156 
the automatic rejection of data outliers. Finally, Fractional Anisotropy (FA), Mean 157 
Diffusivity (MD) and Axial and Radial Diffusivity maps were generated. Diffusion 158 
imaging data quality was assessed by automatically identifying outliers using 159 
residual maps of the tensor fitting and by visually inspecting each subject for major 160 
anatomical abnormalities (21 subjects were excluded from the analysis).  161 
Voxel-wise statistical analysis on FA, MD, axial and radial diffusivity maps was 162 
carried out on the remaining 554 subjects using Tract-Based Spatial Statistics 163 
(TBSS) [32]. All subject’s FA data were registered to the standard MNI space using a 164 
study specific template generated from 50 randomly selected subjects. To exclude 165 
low anisotropic regions, an FA threshold equal to 0.3 was selected to generate the 166 
FA skeleton. A more commonly used FA threshold of 0.2 was also applied to 167 
generate the WM skeleton, yet no significant effects of ApoE genotype from the 168 
TBSS analysis were found. Consequently, we applied a FA threshold equal to 0.3 in 169 
order to restrict the analysis to more anisotropic regions with less significant inter-170 
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subject variability and partial volume effects with grey matter. In other words, we 171 
excluded peripheral tracts that we believe did not assume good tract 172 
correspondence and WM alignment across our subject sample. 173 
Cognitive Assessment  174 
The Block Design and Matrix Reasoning subtests of the Wechsler Intelligence Scale 175 
for Children-Fourth Edition [33]  were computed to generate a Perceptual Reasoning 176 
Index and assess nonverbal intelligence (nonverbal intelligence quotient (IQ)). The 177 
Similarities and Vocabulary subtests were computed to generate a Verbal 178 
Comprehension Index measuring verbal concept formation, that is, the subjects’ 179 
ability to verbally reason (referred to as verbal IQ). 180 
Statistical Analysis 181 
After quality control, 546 subjects from the IMAGEN cohort were used to perform 182 
non-parametric two sample t-tests (5000 permutations) using a generalised linear 183 
model on each diffusion index. Comparisons between carriers and non-carriers of 184 
the ApoE ε4 and ε2 alleles were performed on the diffusion measures and 185 
differences between ApoE ε4 and ε2 carriers were also investigated. Variables of 186 
gender, scan centre, verbal and nonverbal IQ were included as covariates in the 187 
analysis. The R statistical software environment, version 3.1.0, was used to compare 188 
basic demographic statistics by ApoE genotype [34].    189 
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Results 190 
Demographic Characteristics 191 
Healthy adolescents possessing either the ApoE ε4 or ε2 alleles did not significantly 192 
differ in terms of demographics verbal IQ and nonverbal IQ in relation to ApoE ε3/ε3 193 
homozygote carriers. Furthermore, measures of cognitive functioning also did not 194 
significantly differ between the groups (Table 1).  195 
Diffusion Imaging TBSS  196 
In the TBSS analysis, we firstly compared healthy adolescents with at least one 197 
ApoE ε4 allele to non-carriers of the ε4 allele (ε3/ε3 homozygotes and ε3/ε2 carriers). 198 
The analysis revealed no significant differences between carriers and non-carriers of 199 
ApoE ε4 for any index of diffusion (FA, MD, axial and radial diffusivity (respectively 200 
AD and RD)) at a p-value threshold of α = 0.05. Similarly, no significant effect of the 201 
ApoE ε2 genotype was found in ε2 carriers and non-carriers of the allele (ε3/ε3 202 
homozygotes and ε3/ε4 carriers). Furthermore, comparisons between ε4 and ε2 203 
carriers also yielded no significant findings in the TBSS analysis. Although our cohort 204 
had a small number of ε4 homozygote (ε4/ε4) carriers (n=5) and ε2 homozygote (ε2/ 205 
ε2) carriers (n=2), there was no evidence to suggest any ApoE ε4 or ApoE ε2 dose-206 
dependent effects on WM structure. 207 
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Discussion 208 
To our knowledge, this is the first study to investigate the diffusion characteristics of 209 
WM microstructure in relation to ApoE ε4 and ε2 genotype in young healthy 210 
adolescents. Firstly, we investigated the neural effect of the ApoE ε4 genotype on 211 
WM structure and TBSS analysis revealed no significant differences in diffusion 212 
indices including FA, MD, RD, and AD between ε4 carriers and non-carriers.  213 
Previously, we were able to show that no significant differences in hippocampal 214 
volume were present between ApoE ε4 carriers and non-carriers in a wider group of 215 
these young subjects [35]. This finding, along with those from previous structural 216 
imaging studies in older adults, led us to postulate that WM changes could precede 217 
alterations in grey matter – possibly affecting key allocortical fiber pathways that may 218 
reflect ApoE-driven vulnerabilities in the WM network. For instance, Heise and 219 
colleagues [36] were able to demonstrate that the ApoE ε4 allele modulated the WM 220 
structure of young adult carriers despite no evidence of changes in grey matter 221 
structure.  Yet, diffusion-based imaging studies measuring regional patterns of WM 222 
changes in AD and older healthy subjects have reported mixed findings, with some 223 
providing support to the hypothesis of WM degeneration of later-myelinating fibers 224 
[37,38] and others proposing WM damage to the medial temporal lobe and to 225 
prefrontal regions responsible for sustaining memory function [39,40]. In particular, a 226 
number of DTI studies in AD patients and MCI subjects have reported reduced FA 227 
values in multiple regions, however, areas with more consistent findings include the 228 
hippocampal formation [39], parahippocampal gyrus [41] ,and the cingulum bundle 229 
[23,42]. 230 
In contrast, healthy young adult ApoE ε4 carriers studies have also shown reduced 231 
FA values in similar regions known to be affected in patients with AD[43,44], with 232 
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some in the absence of brain fibrillar amyloid plaque deposition [45]. Amyloid β 233 
dysregulation is believed to begin several decades before memory impairment in 234 
sporadic AD. Many studies have since proposed that amyloid biomarkers are the first 235 
to become abnormal in the pathophysiological cascade of the disease. However, 236 
recent structural and functional studies have suggested that tau-mediated 237 
neurodegeneration may precede amyloid pathology in individuals possessing the 238 
ApoE ε4 genotype [46,47]. These findings in young adults have since prompted an 239 
increased interest to address brain changes associated with the ApoE ε4 allele in 240 
infant brain development. In particular, Knickmeyer and colleagues [48] examined 241 
the effect of psychiatric risk variants, including ApoE ε4 genotype, in prenatal brain 242 
development and discovered reduced temporal cortex volumes in ε4 carriers. 243 
However, as the authors of this study had acknowledged, the study sample was 244 
enriched to contain infants with a parental history of psychiatric and neurological 245 
illness. Building on the findings from this study, Dean and colleagues [49] compared 246 
measurements of white matter and gray matter volume in typically-developing infants 247 
with no family history or AD or psychiatric illness. Specifically amongst ApoE ε4 248 
carriers, white matter myelin content and gray matter volumes were reduced in the 249 
precuneus, lateral temporal and middle cingulate – regions of the cortex affected in 250 
late-onset AD. Despite the intriguing result, multiple regions were compared and 251 
most results did not survive multiple comparisons testing, and the number of ε4 252 
carriers was substantially higher than the general population. 253 
In adolescence, brain development represents a major transition in neurobiological 254 
processes which influence specific maturational changes in brain structure and 255 
function. These changes usually optimise the brain for underlying cognitive and 256 
behavioural changes that manifest at the time of puberty onset, but could also confer 257 
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a neural vulnerability to certain forms of psychiatric illness later in life. It is therefore 258 
likely that dynamic stages of individual brain development, such as differences in the 259 
myelination of intra-cortical fibers [50], change in axon calibre [28], and synaptic 260 
density [27] could contribute to a variability in WM networks of adolescents. As a 261 
result, a decrease in statistical sensitivity could be attributed to one or some of these 262 
potential factors.  Nonetheless, our finding that the ApoE ε4 polymorphism does not 263 
modulate WM structure suggests that its effect is not detectable in young 264 
adolescence. Instead, a neuroanatomic effect of ApoE ε4 allele may only become 265 
apparent in later adulthood, particularly when age-related changes in WM structure 266 
begin to gradually decline [51].On the other hand, no genotypic effect of the ApoE ε2 267 
allele was found on any diffusion indices to suggest a protective effect on WM 268 
structure. To date, only one study, by Chiang and colleagues [52] found higher FA 269 
values in the posterior cingulate and anterior corpus collosum, suggesting those 270 
harbouring an ApoE ε2 genotype had more robust WM integrity, and consequently, 271 
decreased vulnerability to AD pathogenesis. In the past, several studies have 272 
proposed to explain the effects of this allele, including cellular models advocating its 273 
role in blocking the aggregation of amyloid β peptides [6,53], and studies reporting 274 
thicker cortices in carrier groups [11,54]. Yet, the neural mechanism of its putative 275 
protective effect still remains unclear.  276 
Our findings should be noted in light of some limitations. Firstly, although TBBS, a 277 
localised statistical method, aims to alleviate problems in residual misalignment, 278 
partial gray matter volume contamination cannot be excluded, especially when the 279 
width of the tract is smaller than the original voxel size [32]. However, thresholding 280 
mean FA values between 0.2 and 0.3 on the WM skeleton has been known to 281 
successfully exclude voxels that are primarily grey matter or CSF [55]. Although the 282 
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procedures used here may be superior to standard registration procedures, the 283 
potential exists to apply more advanced methods that can better quantify the 284 
complexity of white matter changes in the brain using full tensor information [56] and 285 
tract-specific indices of diffusion [57]. Given our observation of no ApoE genotypic 286 
effect on WM structure, it would be interesting for future longitudinal studies to 287 
address when ApoE modulated changes in the WM network begin to manifest and if 288 
they vary with age. Furthermore, since adolescence is a particurarly active 289 
neurodevelopmental period we cannot exclude the possibility of a reduced ApoE 290 
penetrance in this age. Nevertheless, previous studies in younger asymptomatic ε4 291 
carriers  have shown that ApoE plays a fundamental role in modulating brain function 292 
in the absence of any differences in brain volume16. Future studies examining the 293 
pattern of brain activity both at rest and during a memory encoding paradigm in 294 
these individuals will help us understand if genotype-dependent changes in brain 295 
function manifest before structural differences.  296 
Overall, this study demonstrated that individuals possessing the ApoE ε4 and ε2 297 
alleles do not have different WM microstructural properties at a young age (14 298 
years). This suggests that WM structure in young adolescence is not modulated by 299 
the ApoE polymorphism, but may reflect distinct genotype-dependent vulnerabilities 300 
in its structure later during adulthood.   301 
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 ε3 carriers   ε4 carriers (n = 119)  ε2 carriers (n = 55)  
 
ε3/ε3 (n=372)  ε3/ε4 (n=114) ε4/ε4 (n=5)  ε2/ε3 (n=53) ε2/ε2 (n=2) p-value 
 
Age (Years) 14.4 ± 0.5  14.4 ± 0.5 14.6 ± 0.5  14.4 ± 0.5 14.3 ± 0.1 0.975 
Gender (Male/Female) 204/168  68/46 2/3  27/26 0/2 0.662 
Handedness (Right/Left/Both) 321/46/5  106/8/0 4/1/0  48/4/1 2/0/0 0.477 
Verbal IQ 114.0 ± 14.8  114.0 ± 14.7 116.8 ± 20.1  111.5 ± 14.1 125.5 ± 20.5 0.638 
Nonverbal IQ 109.4 ± 13.5  110.4 ± 13.9 103.8 ± 8.3  109.5 ± 12.5 96.0 ± 5.7 0.821 
CANTAB SWM 30.8 ± 5.4  30.7 ± 5.7 29.0 ± 6.0  30.1 ± 5.0 33.0 ± 4.2 0.727 
BMI 20.6 ± 3.4  20.2 ± 2.5 21.0 ± 2.3  20.3 ± 3.2 17.3 ± 2.4 0.446 
WISC Block Design 52.1 ± 8.0  52.5 ± 8.5 49.8 ± 5.0  51.7 ± 7.4 35.0 ± 5.7 0.598 
WISC Matrix Reasoning 27.1 ± 3.7  27.4 ± 3.7 26.0 ± 5.2  27.4 ± 3.8 26.0 ± 1.4 0.790 
WISC Similarities 31.3 ± 4.8  31.6 ± 5.0 33.0 ± 7.5  30.8 ± 4.2 33.5 ± 7.8 0.672 
WISC Vocabulary 51.1 ± 7.5 
 
 51.1 ± 7.6 51.2 ± 9.4  49.9 ± 7.6 60.5 ± 5.0 0.726 
 
Table 1   
Demographic and cognitive characteristics of ApoE ε3 carriers, ε4 carriers and ε2 carriers from the IMAGEN study cohort. 
 
  
 
Values represent Mean ± Standard Deviation.   
A p-value of 0.05 was considered significant for all tests.   
Continuous variables were inspected using analysis of variance (ANOVA) with post-hoc Bonferroni tests and categorical variables (Gender and 
Handedness) were inspected using fisher exact tests.  
Abbreviations: Verbal IQ = verbal intelligence scale, Nonverbal IQ = nonverbal intelligence scale, CANTAB SWM = CANTAB Spatial Working Memory, 
BMI = Body Mass Index, WISC = Wechsler Intelligence Scale for Children.  
All ApoE ε4/ε2 allele carriers were excluded from the study.  
